CELL KINETIC ASPECTS OF HIGH-DOSE THERAPY WITH ARA-C

被引：0
|
作者：
SMETS, LA [1 ]
机构：
[1] ANTONI VANLEEUWENHOEK HOSP,NETHERLANDS CANC INST,AMSTERDAM,NETHERLANDS
来源：
CYTOMETRY | 1981年 / 2卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF HIGH-DOSE ARA-C (HIDAC) - A PHARMACOLOGIC MEANS FOR SELF POTENTIATION
    CAPIZZI, RL
    YANG, JL
    CHENG, E
    SAHASRABUDHE, D
    TAN, RS
    CHENG, YC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 130 - 130
  • [42] CLINICAL-EXPERIENCE WITH HIGH-DOSE ARA-C AND L-ASP
    DICKERHOFF, R
    HAAS, RJ
    ONKOLOGIE, 1985, 8 (01): : 44 - 45
  • [43] Allogeneic bone marrow transplantation compared with high-dose Ara-C postremission therapy in acute myeloid leukemia
    Link, H
    BONE MARROW TRANSPLANTATION, 1998, 22 : S16 - S16
  • [44] TREATMENT OF POOR RISK LEUKEMIA IN CHILDREN WITH HIGH-DOSE ARA-C AND ASPARAGINASE (HD-ARA-C-ASNASE)
    GRUMAYER, ER
    SCHMIDMEIER, W
    GADNER, H
    BLUT, 1985, 51 (03): : 209 - 209
  • [45] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia
    Link, H
    Ehninger, G
    SchonrockNabulsi, P
    Gramatzki, M
    Daoud, A
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Gieseler, F
    Loffler, B
    Weiss, J
    Geer, T
    Wandt, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 840 - 840
  • [46] SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE IN THE THERAPY OF PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ACUTE-LEUKEMIA
    CAPIZZI, RL
    POWELL, BL
    COOPER, MR
    STUART, JJ
    MUSS, HB
    RICHARDS, F
    JACKSON, DV
    WHITE, DR
    SPURR, CL
    ZEKAN, PJ
    CRUZ, JM
    CRAIG, JB
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 105 - 113
  • [47] High-dose MTX and ara-C followed by radiotherapy in primary CNS lymphomas (PCNSL).
    Ambrosetti, A
    Pasini, F
    Todeschini, G
    Nicolato, A
    Miseria, S
    Manno, P
    Pizzolo, G
    Cetto, GL
    BLOOD, 2000, 96 (11) : 233B - 233B
  • [48] PHASE-I TRIAL OF HIGH-DOSE ARA-C AND VP-16
    POWELL, BL
    MUSS, HB
    CAPIZZI, RL
    CAPONERA, ME
    WHITE, DR
    ZEKAN, PJ
    ATKINS, JN
    JACKSON, DV
    RICHARDS, F
    CRAIG, JB
    SPURR, CL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 175 - 175
  • [49] HIGH-DOSE ARA-C AND IDARUBICIN FOR THE TREATMENT OF ADVANCED ACUTE LYMPHOCYTIC LEUKEMIA(ALL)
    AMADORI, S
    TESTI, AM
    MELONI, G
    SPIRITI, MAA
    PULSONI, A
    GROTTO, P
    LADOGANA, S
    LOIACONO, G
    MINIERO, R
    NESPOLI, L
    CARELLA, AM
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 210 - 210
  • [50] HIGH-DOSE ARA-C AND ETOPOSIDE IN THE TREATMENT OF REFRACTORY OR RELAPSING ACUTE-LEUKEMIA
    FREUND, M
    LINK, H
    DIEDRICH, H
    WILKE, JJ
    SCHMOLL, HJ
    POLIWODA, H
    BLUT, 1987, 55 (04): : 215 - 215
12345